Local-Stage Prostate Cancer Incidence Rates Continue to Drop
WEDNESDAY, May 20, 2020 (HealthDay News) — Prostate cancer incidence rates decreased from...
Read More
Hematology/Oncology
Sales of Johnson’s Baby Powder Halted in U.S., Canada
WEDNESDAY, May 20, 2020 (HealthDay News) — Lawsuits claiming that talc-based Johnson’s...
Read More
Multiple Genes Predispose Black Women to Breast Cancer
WEDNESDAY, May 20, 2020 (HealthDay News) — Multiple genes predispose African-American (AA)...
Read More
High BMI in Childhood May Up Risk for Bladder Cancer as Adult
WEDNESDAY, May 20, 2020 (HealthDay News) — Childhood body mass index (BMI) is positively...
Read More
11.2 Percent of Pediatric Cancer Patients Positive for SARS-CoV-2
WEDNESDAY, May 20, 2020 (HealthDay News) — Among pediatric cancer patients, overall...
Read More
Excessive Drinking Seen in Some Patients With Chronic Conditions
WEDNESDAY, May 20, 2020 (HealthDay News) — Among those reporting alcohol use, patients with...
Read More
Prognostic significance of elevated pretreatment serum levels of CEA and CA-125 in epithelial ovarian cancer.
Epithelial ovarian cancer is a highly lethal gynecological malignancy. Accurate and cost-effective...
Read More
Heterogeneity of immune microenvironment in ovarian cancer and its clinical significance: a retrospective study.
Treatment of ovarian cancer (OC) remains the biggest challenge among gynecological malignancies....
Read More
Gold(iii) bis(dithiolene) complexes: from molecular conductors to prospective anticancer, antimicrobial and antiplasmodial agents.
The anticancer, antimicrobial and antiplasmodial activities of six gold(iii) bis(dithiolene)...
Read More
Combined CCNE1 high-level amplification and overexpression is associated with unfavourable outcome in tubo-ovarian high-grade serous carcinoma.
CCNE1 amplification is a recurrent alteration associated with unfavourable outcome in tubo-ovarian...
Read More
Strategic combination therapies for ovarian cancer.
Ovarian cancer remains the leading cause of gynecologic cancer-related death among women...
Read More
AACR 2020: Pre-existing ESR1 Mutations Predict Endocrine Therapy Failure & Poor Survival
Despite research suggesting that mutation in ESR1 is an acquired mechanism of resistance to...
Read More
Conference Highlights: AACR 2020
New research was virtually presented at AACR 2020, the American Association for Cancer Research...
Read More
Pregnancy-related risk factors for sex cord-stromal tumours and germ cell tumours in parous women: a registry-based study.
Non-epithelial ovarian cancers are divided into sex cord-stromal tumours (SCSTs) and germ cell...
Read More
Risk-Reducing Salpingo-Oophorectomy and Breast Cancer Risk Reduction in the Gynecologic Oncology Group Protocol-0199 (GOG-0199).
Risk-reducing salpingo-oophorectomy (RRSO) has been associated with approximately 50% breast...
Read More
The first copper(ii) complex with 1,10-phenanthroline and salubrinal with interesting biochemical properties.
The novel copper complex [Cu(phen)2(salubrinal)](ClO4)2 (C0SAL) has been synthesised and...
Read More
The generally low sensitivity of CA 125 for FIGO stage I ovarian cancer diagnosis increases for endometrioid histotype.
The serum marker CA 125 is still the most widely used biomarker for ovarian cancer (OC) diagnosis...
Read More
Filopodia play an important role in the trans-mesothelial migration of ovarian cancer cells.
Ovarian cancer cells shed from primary tumors can spread easily to the peritoneum via the...
Read More
Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C.
A central and unique aspect of high-grade serous ovarian carcinoma (HGSC) is the extensive...
Read More
Inhibition of collagen XI alpha 1-induced fatty acid oxidation triggers apoptotic cell death in cisplatin-resistant ovarian cancer.
Collagen type XI alpha 1 (COL11A1) is a novel biomarker associated with cisplatin resistance in...
Read More